title: Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase.
authors.affiliation: III. Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Metzgeroth
authors.forename: J
authors.initials: J
authors.lastname: Schwaab
authors.forename: D
authors.initials: D
authors.lastname: Gosenca
authors.forename: A
authors.initials: A
authors.lastname: Fabarius
authors.forename: C
authors.initials: C
authors.lastname: Haferlach
authors.forename: A
authors.initials: A
authors.lastname: Hochhaus
authors.forename: N C P
authors.initials: NC
authors.lastname: Cross
authors.forename: W-K
authors.initials: WK
authors.lastname: Hofmann
authors.forename: A
authors.initials: A
authors.lastname: Reiter
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use*; D001752:Blast Crisis / Q000150:complications / Q000235:genetics* / Q000401:mortality; D004802:Eosinophilia / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D005500:Follow-Up Studies; D015321:Gene Rearrangement; D006801:Humans; D000068877:Imatinib Mesylate; D007951:Leukemia, Myeloid / Q000150:complications / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality; D016399:Lymphoma, T-Cell / Q000150:complications / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D010879:Piperazines / Q000627:therapeutic use*; D011379:Prognosis; D011743:Pyrimidines / Q000627:therapeutic use*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000235:genetics*; D023981:Sarcoma, Myeloid / Q000150:complications / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality; D015996:Survival Rate; D039221:mRNA Cleavage and Polyadenylation Factors / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D015514:Oncogene Proteins, Fusion; D010879:Piperazines; D011743:Pyrimidines; D039221:mRNA Cleavage and Polyadenylation Factors; D000068877:Imatinib Mesylate; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha; D020797:Receptor, Platelet-Derived Growth Factor beta